UCB SA (UCB)

Currency in EUR
222.90
+5.90(+2.72%)
Closed·

UCB Earnings

Latest Release
Jul 30, 2026
EPS / Forecast
-- / 5,04
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/----/------Free Sign Up
2026/06--/5,04--/------Free Sign Up
2026/03--/----/------Free Sign Up
2025/125,59/--4,25B/2,15B--+97,67%Free Sign Up
2025/09--/----/2,15B----Free Sign Up
2025/062,44/--3,49B/1,98B--+76,26%Free Sign Up
2025/03--/----/1,98B----Free Sign Up
2024/124,43/--3,36B/1,97B--+70,56%Free Sign Up
2024/09--/----/1,97B----Free Sign Up
2024/06--/----/1,81B----Free Sign Up

All numbers in EUR

UCB SA Earnings Call Summary for H1/2026

  • UCB reported H1 2026 net sales of EUR 4.1B (+23%) and adjusted EBITDA of EUR 1.7B (+68%), driven by strong demand for its growth portfolio.
  • BIMZELX sales doubled to EUR 1.5B in H1, with management raising peak sales potential to EUR 7B; five growth drivers now exceed 50% of net sales.
  • Company raised FY 2026 guidance to low-to-mid teens revenue growth and mid-teens-to-low 20s EBITDA growth at constant exchange rates.
  • Gross margin improved to 82% from better product mix; core EPS nearly doubled to EUR 6.84 despite upcoming BRIVIACT generic competition pressures.
  • H2 outlook tempered by BRIVIACT exclusivity loss, BIMZELX pricing pressure from expanded access, and higher R&D spending for new clinical programs.
Last Updated: 2026/07/31, 11:20
Read Full Transcript

FAQ

What Is UCB's Earnings Per Share (TTM)?

The UCB EPS (TTM) is 11,52.

When Is The Next UCB Earnings Date?

UCB will release its next earnings report on Oct 27, 2026.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.